FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to methods for detecting tumor cells in the stage of epithelial-mesenchymal transition in ascitic fluids. It can be used in clinical laboratory diagnostics. Method for quantitative estimation of cell fraction in epithelial-mesenchymal passage in ascitic fluid of ovarian cancer using immunofluorescent staining is that from a fixed formaldehyde sample of ascitic fluid a single-cell suspension is prepared, which is stained with double-sandwich antibodies, fluorescence is detected on a flow cytofluorimeter, quantitative analysis of the results presented in the form of dot diagrams in WinMDI 2.9 program, calculating the percentage of cells containing a single and double fluorescent labels.
EFFECT: presented is a method for quantitative assessment of the cell fraction in the epithelial-mesenchymal transition in ascitic fluid and solid tumors of ovarian cancer.
1 cl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR MOLECULAR QUANTITATIVE DETECTION OF LOCAL PREVALENCE OF NON-SMALL CELL LUNG CANCER BY DOUBLE IMMUNOFLUORESCENT STAINING OF NORMAL AND TUMOUR TISSUE | 2020 |
|
RU2732973C1 |
| METHOD FOR IMMUNOFLUORESCENCE ASSAY OF EXCISION REPAIR PROTEIN ERCC1 IN HUMAN SOLID TUMOURS | 2014 |
|
RU2563116C1 |
| METHOD OF FLUORESCENCE IMMUNOASSAY OF OESTROGEN β RECEPTORS IN HUMAN SOLID TUMOURS | 2010 |
|
RU2429481C1 |
| METHOD OF IMMUNOFLUORESCENT ANALYSIS OF MARKERS OF MULTIPLE MEDICATION RESISTANCE IN HUMAN SOLID TUMOURS | 2009 |
|
RU2413948C1 |
| METHOD FOR ESTIMATION OF TOTAL INDICATOR OF ANEUPLOIDY AND PROLIFERATIVE ACTIVITY OF TUMOUR CELLS OF NON-SMALL-CELL LUNG CANCER AND OVARIAN CANCER USING SPECIFIC DNA DYE DRAQ7 OF NEW GENERATION | 2016 |
|
RU2639251C1 |
| METHOD FOR DETECTING TUMOUR CELLS CIRCULATING IN BLOOD BY MULTIPARAMETER FLOW CYTOMETRY | 2024 |
|
RU2825188C2 |
| DIAGNOSTIC TECHNIQUE FOR BREAST CANCER WITH HER2/NEU RECEPTOR EXPRESSION ON A TUMOR CELL MEMBRANE | 2018 |
|
RU2701356C1 |
| MULTIPLEX DETECTION OF TUMOUR CELLS WITH USING PANEL OF AGENTS BINDING TO EXTRACELLULAR MARKERS | 2008 |
|
RU2489720C2 |
| METHOD FOR SUPPRESSING THE INDUCING ACTION OF HIGH MOLECULAR WEIGHT HYALURONIC ACID ON BREAST CANCER STEM CELLS | 2021 |
|
RU2774031C1 |
| METHOD FOR PRECURSOR CELL (CD34+) MEASUREMENT IN BLOOD-FORMING TISSUE | 2012 |
|
RU2513511C1 |
